Abstract:
Various embodiments of a biological interface system and related methods are disclosed. The system may comprise a sensor comprising a plurality of electrodes for detecting multicellular signals emanating from one or more living cells of a patient and a processing unit configured to receive the multicellular signals from the sensor and process the multicellular signals to produce a processed signal. The processing unit may be configured to transmit the processed signal to a controlled device that is configured to receive the processed signal. The system is configured to perform an integrated patient training routine to provide a time varying stimulus to the patient and to generate one or more system configuration parameters used by the processing unit to produce the processed signal.
Abstract:
The present invention provides an apparatus and a method wherein the movement of analytes on a chromatographic separation column is controlled by the manipulation of isocratic and gradient flow. Such manipulation allows for a distinct set of analytes to be eluted from the chromatography column and delivered downstream for further separation and/or processing while the remainder of the sample remains in a “holding pattern” on the chromatography column. As such, the present invention allows for a small portion of the sample to be processed downstream of the column while substantially eliminating undesirable isocratic elution from the column during such downstream processing. Once the downstream processing has been completed, the column of the present invention elutes a second distinct analyte and the remainder of the sample is maintained in a holding pattern. The process may be repeated until the entire sample has been eluted from the chromatography column.
Abstract:
A toner for developing an electrostatic image comprising toner particles which include a binder resin, a wax and a colorant, wherein the wax has a melting point of between 50 and 150° C., the wax exists in the toner particles in domains of 2 μm or less mean particle size and (a) the mean circularity of the toner particles as measured by a Flow Particle Image Analyser is at least 0.90; and (b) the shape factor, SF1, of the toner particles is at most 165. A process for the manufacture of said toner which comprises the following steps: providing a latex dispersion; providing a wax dispersion; providing a colorant dispersion; mixing the latex dispersion, wax dispersion and colorant dispersion; and causing the mixture to flocculate.